Mechanistically, the induction of the expressions of IL-6, IL-4, IL-13, Mcpt7, TRPA1, and TRPV1 in the EB model were significantly reduced upon CTM treatment (Fig. 7). The gene discussed is TRPA1; the disease is epidermolysis bullosa.